Breaking News

CONTINUUS Awarded $69.3M DoD Grant

Will enable construction of the country's first GMP facility for end-to-end, ICM-driven production of small-molecule drugs in Woburn, MA.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CONTINUUS Pharmaceuticals Inc., a producer of small-molecule pharmaceuticals leveraging its Integrated Continuous Manufacturing (ICM) technology, received a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including COVID-19.   The contract, awarded by the Department of Defense (DoD) in conjunction with the Department of Health and Human Services (HHS), will also enable construction of the country’s f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters